FDA Data Integrity Guide Ends Excuses For Suspect Records

The U.S. Food and Drug Administration on Thursday explained how drugmakers can minimize doubts about the integrity of their manufacturing data, a move that will prove helpful but also eliminate excuses...

Already a subscriber? Click here to view full article